Stockchase Opinions

Jim Cramer - Mad MoneyAbCellera BiologicsABCLCOMMENTMay 16, 2022

They're okay. Shares have fallen, but the company makes money.
$7.81

Stock price when the opinion was issued

$6.29

As of Jul 17, 2026. Market Open.

biotechnology
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

DON'T BUY
This biotech is purely speculative. He ain't playin'.
RISKY
It's a spec play, but he likes the biologics space.